New antibiotic could be effective against resistant bacteria
A new class of antibiotics has shown promising results against an antibiotic-resistant bacterium in initial studies. However, the active ingredient developed by researchers at the pharmaceutical company Roche in Basel is still a long way from being used in practice.
This content was published on
2 minutes
Keystone-SDA
العربية
ar
مضادات حيوية جديدة قد تكون فعالة ضد بكتيريا مقاومة
According to the study published on Wednesday in the scientific journal “Nature”, the newly developed active substance called zosurabalpine was effective in the laboratory and in mice against the antibiotic-resistant bacterium Acinetobacter baumannii – a typical hospital germ that can cause pneumonia, for example.
Antibiotic resistance has become an acute threat to health in recent decades, the researchers emphasised in the study. The bacterium targeted by the new active ingredient is particularly worrying. This is because it belongs to the so-called gram-negative bacteria, which are surrounded by inner and outer membranes that are difficult for most antibiotics to overcome. It repeatedly leads to outbreaks of infection in intensive care units around the world.
“Any new class of antibiotics that is able to treat infections caused by multidrug-resistant bacteria such as carbapenem-resistant Acinetobacter baumannii would be a major breakthrough,” said Michael Lobritz from Roche, who was involved in the study, when asked by the Keystone-SDA news agency. However, further studies are needed to know whether Zosurabalpine will bring about this breakthrough.
More
Debate
Hosted by:
Jessica Davis Plüss
How has the pandemic affected your view of the pharmaceutical industry?
To some people, pharmaceutical companies are the heroes of the pandemic. To others, they are to blame for the challenges ending the pandemic.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Foreign affairs
European nations snub Swiss-made weapons over Ukraine restrictions
NGO accuses tobacco industry and Switzerland of human rights violations
This content was published on
The anti-smoking NGO OxySuisse has accused tobacco companies of violating human rights and the Swiss authorities of being complacent.
Swiss national injured in attack on Beirut building
This content was published on
A Swiss national was slightly injured following an attack on a building in Beirut, Swiss media agency Keystone-ATS learned on Tuesday.
Kate Winslet receives Golden Icon award at Zurich Film Festival
This content was published on
British actress Kate Winslet took a dip in Lake Zurich before receiving the Golden Icon Award for lifetime achievement at the Zurich Film Festival.
Swiss President remembers victims of October 7 attack
This content was published on
One year after the attack on Israel by Hamas, Swiss President Viola Amherd remembered the victims and called for the release of all hostages.
Lausanne public transport to go all-electric by 2030
This content was published on
The company that runs public transport in the Swiss city of Lausanne intends to convert its entire fleet of vehicles to electric power within the next five years.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.